Search
for
Sort by
Research 811–840 of 1000+
- Scarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib
- Invasion and increased expression of S100A4 and CYR61 in mesenchymal transformed breast cancer cells is downregulated by GnRH
- Sorafenib-induced eruption resembling pityriasis rubra pilaris
- Upregulation of the truncated basic hair keratin 1(hHb1‐ΔN) in carcinoma cells by Epstein‐Barr virus (EBV)
- Recent discoveries and developments of androgen receptor based therapy for prostate cancer
- Cetuximab-induced hypertrichosis of the scalp and eyelashes
- Induction of ferroptosis by natural products in non-small cell lung cancer: a comprehensive systematic review
- Adverse Reaction to Cetuximab, an Epidermal Growth Factor Receptor Inhibitor.
- Role of sgk1 in cancer: a bibliometric analysis from 2013 to 2023—review article
- Complex Scalp Reconstruction with Super Thin DIEP Free Flap
- SUN-911 Immunotherapy Use in Adrenocortical Carcinoma with Encouraging Results- a Case Report
- Updates from the British Association of Dermatologists 91st Annual Meeting, 5-7 July 2011, London, U.K.
- A matter of excessive hair growth
- Tyrosine Kinase Inhibitors against Cancer: Their Safety in 216 Moroccan Patients
- Cetuximab Induced Hidrocystomas: A Case Report
- Posters Presented at the 19th Joint Meeting of the International Society of Dermatopathology, March 2–3, 2016, Hilton Crystal City at Washington Reagan National Airport, Arlington, Virginia, USA
- 696 MEK and BRAF inhibitors augment the production and accumulation of sebum in hamster sebocytes
- 412 DETECTION OF CIRCULATING PROSTATE CANCER CELLS BY MEANS OF AN ANTIBODY-CONJUGATED NANOPARTICULAR BIOSENSOR
- Molecular mechanisms of androgen receptor functions
- RANK as a therapeutic target in cancer
- The use of scalp cooling for chemotherapy-induced hair loss
- Matriptase: Potent Proteolysis on the Cell Surface
- Three-Month Treatment With a Long-Acting Gonadotropin-Releasing Hormone Agonist of Patients With Benign Prostatic Hyperplasia: Effects on Tissue Androgen Concentration, 5<i>α</i>-Reductase Activity and Androgen Receptor Content*
- Androgen receptors and their biology
- Two Opposing Faces of Retinoic Acid: Induction of Stemness or Induction of Differentiation Depending on Cell-Type
- Therapeutic Strategies to Target the Androgen Receptor
- Postscreening follow-up of the Finnish Prostate Cancer Screening Trial on putative prostate cancer risk factors: vitamin and mineral use, male pattern baldness, pubertal development and non-steroidal anti-inflammatory drug use
- Clinical Case Notes. Intraorbital ophthalmic artery aneurysms
- 5α‐Reductase Inhibitors
- Sorafenib-Associated Facial Acneiform Eruption